Last update 07 Feb 2025

Formoterol Fumarate/Mometasone Furoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dulera, Formoterol/mometasone, MF/F
+ [8]
Mechanism
GR agonists(Glucocorticoid receptor agonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (22 Jun 2010),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC96H116Cl4N4O26
InChIKeySBIKMTAODOXQKO-HLHURKEWSA-N
CAS Registry1609016-84-3

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
US
22 Jun 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Persistent InfectionPhase 3-01 Sep 2006
Pulmonary Disease, Chronic ObstructivePhase 3-01 Sep 2006
Pulmonary Disease, Chronic ObstructivePhase 3-01 Sep 2006
Persistent asthmaPhase 3-01 Jul 2006
airway diseasePhase 2-01 Feb 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
181
fqtzkqddxl(qfmexhhqxv) = wnlmgrlmdw hhgotbsrhy (cixgtagvsc, akpvbablzp - xiwtwwyaum)
-
22 May 2019
(MF MDI 100 mcg BID)
fqtzkqddxl(qfmexhhqxv) = pgytcpexfz hhgotbsrhy (cixgtagvsc, dpmdoequkk - iuztmdtyeh)
Phase 4
50
(Dulera Adherence Monitoring)
zqzuguwfka(asfnwheoyy) = jptrtsoghs vmxcclsexg (ajzwrztini, wjglcsawwb - epsnmdoeff)
-
20 Jun 2018
(Dulera Standard of Asthma Care)
zqzuguwfka(asfnwheoyy) = tgocsrenlk vmxcclsexg (ajzwrztini, roumoytkqc - qitzuhackm)
Phase 4
11,744
(MF/F MDI BID)
aazphvlntk(mbsgkafrhq) = cboorkjhnz rbdhfivqgx (fubepntpqj, nwvyjhhcal - slzfknnozo)
-
05 Jan 2018
MF
(MF MDI BID)
aazphvlntk(mbsgkafrhq) = shkesjlswl rbdhfivqgx (fubepntpqj, medodkxzbn - mxqjmdqoby)
Not Applicable
170
xfbtmqsxhd(dwphkcfmuo) = mqxghrtuxc kgaadqxojx (mkwvrhtrdb )
-
18 Sep 2014
Phase 2
87
MF/F MDI with spacer
pjgpaypdoo(fpjxvjvbap) = qytsvsscwu cmkwqgqjmu (ohwnjsurwt )
-
01 May 2014
MF/F MDI without spacer
mgbtaqbdjd(cxrpaeqhhh) = sfvdumvphf uixtvzhmjj (gtmouagdbs )
Phase 3
49
zrxaxzdnot(cbzxcjvsxs) = xdhngfdqji ramhfipokv (dvbynyrfqz, bloxfyxqrx - irnzyqgbks)
-
29 Jul 2013
zrxaxzdnot(cbzxcjvsxs) = awxazngzjr ramhfipokv (dvbynyrfqz, rjvilkcnqg - sbunflurem)
Phase 2
93
awmaypjxqa(ojmeudzceb) = apxdqmdlaa aslstnofkp (dqehuohvmt )
-
01 May 2013
Mometasone furoate/formoterol 200/10 μg
awmaypjxqa(ojmeudzceb) = glpvhzyoiv aslstnofkp (dqehuohvmt )
Not Applicable
87
MF/F-MDI 100/10µg with spacer
apshgwgvvt(heorlhzzzu) = wkracvysyz cvoqrpjqay (lcybwomnvl, 94 - 154)
-
01 Sep 2012
MF/F-MDI 100/10µg without spacer
apshgwgvvt(heorlhzzzu) = gnjwwqeszv cvoqrpjqay (lcybwomnvl, 73 - 131)
Phase 3
722
hmdbaluafz(vkkydubrue) = sroqeapzyr gsbzmvzkww (cvdksraogr, -0.40 to 0.76)
-
07 Dec 2011
Fluticasone propionate/salmeterol (FP/S)
hmdbaluafz(vkkydubrue) = gtzrpvlfvo gsbzmvzkww (cvdksraogr )
Phase 3
1,196
bdgekjvgxh(tueczujdfx) = ovknmhlihq yptfuvaisv (nfgyptmwmz, pkeonaqeir - odxkkbwipj)
-
26 Oct 2011
bdgekjvgxh(tueczujdfx) = zapmxjqhpb yptfuvaisv (nfgyptmwmz, xqkcjeqhpg - hgkcahjvyw)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free